ABUS
Arbutus Biopharma Corp

16,825
Mkt Cap
$921.23M
Volume
1.28M
52W High
$5.10
52W Low
$2.71
PE Ratio
-21.60
ABUS Fundamentals
Price
$4.87
Prev Close
$4.79
Open
$4.85
50D MA
$4.56
Beta
0.90
Avg. Volume
1.32M
EPS (Annual)
-$0.3767
P/B
11.88
Rev/Employee
$140,250.00
Loading...
Loading...
News
all
press releases
Arbutus Biopharma (NASDAQ:ABUS) Shares Up 6% - Still a Buy?
Arbutus Biopharma (NASDAQ:ABUS) Trading 6% Higher - Here's What Happened...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Share Price Passes Above Two Hundred Day Moving Average - Time to Sell?
Arbutus Biopharma (NASDAQ:ABUS) Shares Cross Above 200-Day Moving Average - What's Next...
MarketBeat·14d ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Stock Price Down 6.4% - What's Next?
Arbutus Biopharma (NASDAQ:ABUS) Trading Down 6.4% - Time to Sell...
MarketBeat·22d ago
News Placeholder
Arbutus Biopharma Corporation $ABUS Shares Purchased by Two Seas Capital LP
Two Seas Capital LP increased its holdings in shares of Arbutus Biopharma Corporation (NASDAQ:ABUS - Free Report) by 10.3% during the 2nd quarter, according to its most recent Form 13F filing with...
MarketBeat·1mo ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Given Buy Rating at Chardan Capital
Chardan Capital reiterated a "buy" rating and issued a $5.00 price target on shares of Arbutus Biopharma in a research report on Friday...
MarketBeat·2mo ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Downgraded by Wall Street Zen to Hold
Wall Street Zen cut Arbutus Biopharma from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·2mo ago
News Placeholder
Arbutus Biopharma (NASDAQ:ABUS) Posts Quarterly Earnings Results, Beats Expectations By $0.01 EPS
Arbutus Biopharma (NASDAQ:ABUS - Get Free Report) released its quarterly earnings data on Wednesday. The biopharmaceutical company reported ($0.04) EPS for the quarter, topping analysts' consensus...
MarketBeat·2mo ago
News Placeholder
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
Here is how Arbutus Biopharma (ABUS) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
Is Novartis (NVS) Stock Outpacing Its Medical Peers This Year?
Here is how Novartis (NVS) and Arbutus Biopharma (ABUS) have performed compared to their sector so far this year.
Zacks·4mo ago
News Placeholder
Is Arbutus Biopharma (ABUS) Stock Outpacing Its Medical Peers This Year?
Here is how Arbutus Biopharma (ABUS) and Armata Pharmaceuticals, Inc. (ARMP) have performed compared to their sector so far this year.
Zacks·4mo ago
<
1
2
...
>

Latest ABUS News

View

Advertisement|Remove ads.

Advertisement|Remove ads.